表紙
市場調查報告書

有效性實驗的全球市場

Efficacy Testing

出版商 Global Industry Analysts, Inc. 商品編碼 906620
出版日期 內容資訊 英文 689 Pages
商品交期: 最快1-2個工作天內
價格
有效性實驗的全球市場 Efficacy Testing
出版日期: 2020年10月01日內容資訊: 英文 689 Pages
簡介

本報告提供有效性實驗的世界市場調查,提供市場概要,各市場區隔(用途·產品 & 服務)·各地區的市場佔有率,市場趨勢及市場佔有率分析,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
    • 競爭企業的市場佔有率:各市場區隔
    • 消耗品
    • 服務·設備
  • 關注企業
  • 市場趨勢和成長要素
  • 市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 消耗品
    • 服務·設備
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭情形

  • AMERICAN TYPE CULTURE COLLECTION
  • CHARLES RIVER LABORATORIES INTERNATIONAL
  • EUROFINS SCIENTIFIC
  • MERCK KGAA
  • NORTH AMERICAN SCIENCE ASSOCIATES, INC.
  • PACIFIC BIOLABS
  • SGS SA
  • TOXIKON CORPORATION
  • WUXI APPTEC
  • BIOMeRIEUX SA

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP11684

Growing Competition in Consumer Markets, Plethora of Products With Myriad Claims Means Consumers Increasingly Want Proof of Efficacy. Efficacy Testing to Reach $866.3 Billion

The global market for Efficacy Testing is projected to reach US$866.3 million by the year 2027, trailing a post COVID-19 CAGR of 10.7% over the analysis period 2020 through 2027. Cosmetics, food and pharma companies are streamlining and revising the ingredients used in formulations continuously for optimized cost and efficacy. In the pharmaceuticals Industry, drug efficacy testing is important to validate safest and most efficient active compounds. Stringent FDA drug approval regulations are leading to increased preclinical drug efficacy testing. Pharma giants are increasingly outsourcing testing to drug efficacy testing service providers in a bed to cut costs. Using animal models is a popular way to test compounds for their effectiveness on specific diseases. The manufacturing of generic drugs as a key trend in the pharmaceutical industry also bodes well for growth in the market. With branded drugs taking around 7-10 years to reach commercialization, generic drugs are much more popular, as they take relatively less time to reach complete potential. Generic drugs are described as the bioequivalent versions of branded drugs in terms of safety, quality, stability, impact, strength, dosage form, and route of administration. Over the years, generic drugs have emerged as safe and effective alternatives to the brand name formulations. The generic variants often different from brand names in terms of certain characteristics such as color, flavoring and shape, although these factors do not have any impact on the safety and efficacy of the medicines compared to the original version. Generic drugs are made using the same active ingredients that are utilized in branded drugs. A key advantage for generic drug makers is that they do not need to invest time and money into drug R&D and marketing efforts, whereby the generic drugs are priced considerably low compared to branded counterparts. As generic drug making companies focus on the speed factor to ensure access to first-to-file status, efficacy testing becomes more important than before.

With growing number of products with beauty claims being launched in the market, the cosmetics industry is coming under intense scrutiny. Manufacturers are coming under increased pressure to support their product claims. Cosmetic efficacy testing is growing in value and popularity on par with the competitive need to innovate newer & better performing products. Educated and aware customers are also increasingly demanding evidentiary support for products' claims. Also growing in popularity and importance are preservative efficacy test (PET) for cosmetics. Cosmetics manufacturers of today are facing the challenges associated with preservatives. While these companies must ensure that their products are free from harmful microorganisms and safe for use, they also need to contend with increasing consumer criticism against the use of such preservatives. For decades, parabens remained the first choice as preservatives for cosmetic products. Parabens are simple esters that offer an easy and effective way of imparting antimicrobial agents into moisturizers, haircare, and other makeup products. A study conducted in 1995 found that 99% of cosmetics contained parabens. In the early 2000s, there were shifts in the perceptions of safety of parabens due to studies showing that esters cause estrogenic effects. Since estrogenic chemicals are shown to play a key role in breast cancer, deeper research was taken up to find whether parabens are rapidly metabolized and excreted always, or they might linger in the body in some cases and be potentially harmful. By 2004, there were mounting concerns about the safety of esters when researchers showed the accumulation of intact parabens in human breast tumors. This is driving cosmetics manufacturers to look for alternative techniques of preservation. The past decade demonstrated the difficulty of finding preservatives with a broad and spectrum of antimicrobial effects with the robustness required to ensure safety while being sufficiently mild to avoid any negative interaction with other ingredients. Hurdle Technology, as the very name suggests, creates a series of hurdles, which might not be individually big enough to avert contamination, collectively, as back-to-back hurdles, they keep the microorganisms in control.

Health and wellness trend is ballooning into a major trend catalyzed by the COVID19 pandemic and the obsession with immunity building. The trend towards naturals has triggered robust growth in botanical research studies as increasing number of herbs and plant compounds are added to health products and dietary supplements. There is strong demand for bio-assays to test efficacy & biological activity of herbal ingredients in products. Of late, significant focus has been shed on regulating nutraceuticals and monitoring their efficacy claims. Convenience food has and will continue to remain a major trend in the food industry. With the packaged foods industry flooded with foods with various health claims, nutrition label analysis is growing in importance. Growing incidence of food fraud is throwing the spotlight on stricter regulations to ensure manufacturers take responsibility for food safety, traceability, recall and notification. A growing number of laboratories are beginning offer ingredient analysis services to analyze food products for their physical, chemical and microbiological properties.

Competitors identified in this market include, among others,

  • American Type Culture Collection (ATCC)
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Merck KgaA
  • North American Science Associates, Inc.
  • Pacific Biolabs
  • SGS SA
  • Toxikon Corporation
  • Wuxi Apptec Co., Ltd.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Efficacy Testing
    • Global Efficacy Testing Market Poised for Steady Growth
    • US Dominates, Asia-Pacific to Witness Rapid Growth
    • Anti-microbial/Preservative Efficacy Testing to Register Rapid Growth
    • Disinfectant Efficacy Testing Dominates
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
    • Recent Market Activity
  • 3. MARKET TRENDS & DRIVERS
    • Rising Importance of Preservative Efficacy Testing
    • Challenge Organisms
    • Testing Techniques
    • Challenges
    • Conclusion
    • Preservation Technique for Paraben-Free Cosmetics
    • Development of Alternative Techniques of Preservation
    • Adoption of Hurdle Technology
    • Preservative Systems in Liquid Dietary Supplements
    • Preservative Efficacy Test (PET) for Cosmetics
    • Efficacy Testing for Cosmetics
    • Techniques Employed for Demonstrating Effectiveness of Disinfectants
    • Categorization of Test Types
    • Surface Testing
    • Additional Tests Mandated for the Pharmaceuticals Industry by the USP
    • Contact Time Defined
    • Strong Rise in Pharmaceutical Sales to Drive Demand for Efficacy Testing
    • EXHIBIT 1: Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Rapid Growth of Generic Drugs Drives Demand for Pharma Efficacy Testing
    • EXHIBIT 2: Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2022 & 2025
    • Aging Population Propels the Demand for Ethicacy Testing in End-use Applications
    • EXHIBIT 3: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Increasing Healthcare Expenditure to Foster Growth
    • EXHIBIT 4: World Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, 2021 & 2023
    • Persistent Increase in Pharmaceutical R&D Bodes Well for Efficacy Testing
    • Rising Incidence of Chronic Diseases Fuels Demand for Efficacy Testing
    • EXHIBIT 5: Global Cancer Incidence by Region: 2018
    • EXHIBIT 6: Global Cancer Incidence by Type: 2018
    • EXHIBIT 7: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • EXHIBIT 8: Rising Diabetes Prevalence Presents Opportunity for Cell Harvesting: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Consumables Segment Leads the Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Disinfectant Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Disinfectant Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Disinfectant Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Antimicrobial Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Antimicrobial Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Antimicrobial Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Pharmaceutical Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Pharmaceutical Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Pharmaceutical Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Cosmetics & Personal Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Cosmetics & Personal Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Cosmetics & Personal Care Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 29: USA Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: USA 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 32: USA Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: USA 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 35: USA Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: USA 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 38: Canada Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: Canada 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: Canada Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: Canada 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: Canada Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: Canada 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 46: Japan Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: Japan Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: Japan 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Japan Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Japan 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Japan Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Japan 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 55: China Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: China Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: China 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: China Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: China 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: China Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: China 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 64: Europe Current & Future Analysis for Efficacy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 65: Europe Historic Review for Efficacy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: Europe 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Europe Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: Europe 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: Europe Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: Europe 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: Europe Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: Europe 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: France Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: France 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: France Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: France 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: France Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: France 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Germany Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: Germany 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Germany Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: Germany 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: Germany Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: Germany 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: Italy Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: Italy 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Italy Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: Italy 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Italy Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: Italy 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: UK Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: UK 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: UK Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: UK 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: UK Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: UK 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 112: Spain Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Spain Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: Spain 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Spain Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: Spain 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 118: Spain Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: Spain Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: Spain 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 121: Russia Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: Russia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: Russia 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Russia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: Russia 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 127: Russia Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Russia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Russia 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Rest of Europe Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: Rest of Europe 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Rest of Europe Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: Rest of Europe 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: Rest of Europe Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: Rest of Europe 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 139: Asia-Pacific Current & Future Analysis for Efficacy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 140: Asia-Pacific Historic Review for Efficacy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 141: Asia-Pacific 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Asia-Pacific Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 144: Asia-Pacific 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Asia-Pacific Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 147: Asia-Pacific 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 149: Asia-Pacific Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 150: Asia-Pacific 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 151: Australia Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 152: Australia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 153: Australia 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 155: Australia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 156: Australia 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 157: Australia Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 158: Australia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 159: Australia 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 160: India Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 161: India Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 162: India 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 164: India Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 165: India 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 166: India Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 167: India Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 168: India 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 169: South Korea Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 170: South Korea Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 171: South Korea 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 173: South Korea Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 174: South Korea 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 176: South Korea Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 177: South Korea 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 179: Rest of Asia-Pacific Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 182: Rest of Asia-Pacific Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 185: Rest of Asia-Pacific Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 187: Latin America Current & Future Analysis for Efficacy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 188: Latin America Historic Review for Efficacy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 189: Latin America 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 191: Latin America Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 192: Latin America 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 194: Latin America Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 195: Latin America 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 197: Latin America Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 198: Latin America 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 199: Argentina Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 200: Argentina Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 201: Argentina 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 203: Argentina Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 204: Argentina 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 206: Argentina Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 207: Argentina 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 208: Brazil Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 209: Brazil Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 210: Brazil 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 212: Brazil Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 213: Brazil 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 215: Brazil Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 216: Brazil 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 217: Mexico Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 218: Mexico Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 219: Mexico 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 221: Mexico Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 222: Mexico 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 224: Mexico Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 225: Mexico 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 226: Rest of Latin America Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 227: Rest of Latin America Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 228: Rest of Latin America 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 230: Rest of Latin America Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 231: Rest of Latin America 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 233: Rest of Latin America Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 234: Rest of Latin America 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 235: Middle East Current & Future Analysis for Efficacy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 236: Middle East Historic Review for Efficacy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 237: Middle East 15-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 239: Middle East Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 240: Middle East 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 242: Middle East Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 243: Middle East 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 245: Middle East Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 246: Middle East 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 247: Iran Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 248: Iran Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 249: Iran 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 251: Iran Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 252: Iran 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 253: Iran Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 254: Iran Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 255: Iran 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 256: Israel Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 257: Israel Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 258: Israel 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 260: Israel Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 261: Israel 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 262: Israel Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 263: Israel Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 264: Israel 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 265: Saudi Arabia Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 266: Saudi Arabia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 267: Saudi Arabia 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 269: Saudi Arabia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 270: Saudi Arabia 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 272: Saudi Arabia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 273: Saudi Arabia 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 274: UAE Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 275: UAE Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 276: UAE 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 278: UAE Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 279: UAE 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 280: UAE Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 281: UAE Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 282: UAE 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 283: Rest of Middle East Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 284: Rest of Middle East Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 285: Rest of Middle East 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 287: Rest of Middle East Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 288: Rest of Middle East 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 290: Rest of Middle East Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 291: Rest of Middle East 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 292: Africa Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 293: Africa Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 294: Africa 15-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2012, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 296: Africa Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 297: Africa 15-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2012, 2020 & 2027
    • TABLE 298: Africa Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 299: Africa Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 300: Africa 15-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 70